CA2443813A1 - Method for identification of proteins from intracellular bacteria - Google Patents

Method for identification of proteins from intracellular bacteria Download PDF

Info

Publication number
CA2443813A1
CA2443813A1 CA002443813A CA2443813A CA2443813A1 CA 2443813 A1 CA2443813 A1 CA 2443813A1 CA 002443813 A CA002443813 A CA 002443813A CA 2443813 A CA2443813 A CA 2443813A CA 2443813 A1 CA2443813 A1 CA 2443813A1
Authority
CA
Canada
Prior art keywords
proteins
protein
gene name
chlamydia
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002443813A
Other languages
English (en)
French (fr)
Inventor
Allan Christian Shaw
Brian Berg Vandahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2443813A1 publication Critical patent/CA2443813A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
CA002443813A 2001-04-09 2002-04-09 Method for identification of proteins from intracellular bacteria Abandoned CA2443813A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28251301P 2001-04-09 2001-04-09
DKPA200100581 2001-04-09
US60/282,513 2001-04-09
DKPA200100581 2001-04-09
PCT/DK2002/000234 WO2002082091A2 (en) 2001-04-09 2002-04-09 Method for identification of proteins from intracellular bacteria

Publications (1)

Publication Number Publication Date
CA2443813A1 true CA2443813A1 (en) 2002-10-17

Family

ID=26069005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002443813A Abandoned CA2443813A1 (en) 2001-04-09 2002-04-09 Method for identification of proteins from intracellular bacteria

Country Status (9)

Country Link
EP (1) EP1412757A2 (xx)
JP (1) JP2004534526A (xx)
KR (1) KR20040002905A (xx)
CN (1) CN1531653A (xx)
BR (1) BR0208786A (xx)
CA (1) CA2443813A1 (xx)
IL (1) IL158136A0 (xx)
MX (1) MXPA03009222A (xx)
WO (1) WO2002082091A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
GB0409748D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
AU2008246064A1 (en) 2007-05-01 2008-11-06 The Board Of Regents Of The University Of Texas System Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
US7892567B2 (en) 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
EP2342215A4 (en) 2008-10-09 2012-06-27 Univ Texas METHODS AND COMPOSITIONS FOR CHLAMYDIA ANTIGENS FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIA DISEASES AND INFECTIONS
WO2011087822A1 (en) 2009-12-22 2011-07-21 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
CN102749233A (zh) * 2012-06-04 2012-10-24 王新华 一种maldi-tof ms直接检测感染尿液病原菌前处理方法
NL2019320B1 (en) * 2017-03-02 2018-09-21 Biosparq B V Diagnostic method and system for diagnosis
CN112175955B (zh) * 2020-10-29 2022-05-24 西南大学 一种在植物花粉中特异表达的强启动子cp09及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021407A4 (en) * 1997-08-15 2001-07-04 Millennium Pharm Inc SYNTHESIS OF CLASTO-LACTACYSTINE BETA-LACTONE AND ITS ANALOGS
DE69836977T2 (de) * 1997-11-21 2007-10-18 Serono Genetics Institute S.A. Chlamydia pneumoniae genomische sequenzen und polypeptiden, fragmenten und anwendungen davon für nachweis, prevention und heilung
EP2218731A1 (en) * 1997-11-28 2010-08-18 Merck Serono Biodevelopment Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection

Also Published As

Publication number Publication date
WO2002082091A3 (en) 2004-03-04
EP1412757A2 (en) 2004-04-28
KR20040002905A (ko) 2004-01-07
MXPA03009222A (es) 2004-11-12
WO2002082091A2 (en) 2002-10-17
CN1531653A (zh) 2004-09-22
IL158136A0 (en) 2004-03-28
JP2004534526A (ja) 2004-11-18
BR0208786A (pt) 2004-03-09

Similar Documents

Publication Publication Date Title
US20030199438A1 (en) Method for identification of proteins from intracellular bacteria
Vandahl et al. Proteome analysis of the Chlamydia pneumoniaeelementary body
CA2476755C (en) Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
US20090011426A1 (en) Methods of Diagnosis and Treatment of M.Tuberculosis Infection and Reagents Therefor
CA2443813A1 (en) Method for identification of proteins from intracellular bacteria
Finco et al. Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings
US8298778B2 (en) Method and kit for detecting antibody to avibacterium paragallinarum
JP2004534526A5 (xx)
AU2009302821A1 (en) Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
Tomson et al. Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins
AU2008246064A1 (en) Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
Wang et al. Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates
US10273278B2 (en) Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
US20110212133A1 (en) Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor
WO2007131293A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor vi
AU2002338351A1 (en) Method for identification of proteins from intracellular bacteria
US20100203075A1 (en) Chlamydia antigens
DelVecchio et al. Proteomics for the development of vaccines and therapeutics
WO2007131291A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore
WO2007131292A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor xi
AU2005256177A1 (en) Novel methods of diagnosis of treatment of P. aeruginosa infection and reagents therefor
WO2003082317A9 (en) Peptide epitopes recognized by antigen specific cd8+ t lymphocytes
CHRISTIANSEN et al. SVEND BIRKELUND
Skipp The development and application of protemics to the analysis of Chlamydia Trachomatis
US20060073531A1 (en) Anti-chlamydial antibodies and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued